Journal of Medical Academics

Register      Login

VOLUME 4 , ISSUE 1 ( January-June, 2021 ) > List of Articles


COVID-19 Vaccine Hesitancy in the Adult General Population of India

Shubhangini Sachdeva, Sridhar Mangalesh, Sharmila Dudani

Keywords : Coronavirus disease-2019, Infection, Pandemic, Vaccination refusal, Vaccine

Citation Information : Sachdeva S, Mangalesh S, Dudani S. COVID-19 Vaccine Hesitancy in the Adult General Population of India. Journal of Medical Academics 2021; 4 (1):19-23.

DOI: 10.5005/jp-journals-10070-0070

License: CC BY-NC 4.0

Published Online: 01-12-2021

Copyright Statement:  Copyright © 2021; The Author(s).


Aim and background: Two vaccines for coronavirus disease-2019 (COVID-19), by Bharat Biotech and Serum Institute of India, have been approved by the Indian Government for administration. This study attempts to analyze vaccine hesitancy in the general adult population of India. Materials and methods: A pan-India cross-sectional survey, adapted for GoogleForms®, was circulated before the rollout of vaccines to assess vaccine hesitancy. Continuous variables are expressed as mean ± SD and categorical variables as a percentage. The Chi-square test was used for associations. Results: Seven hundred and sixty-two responses were analyzed. 27.2% of respondents demonstrated vaccine hesitancy. 59.4% of vaccine acceptors preferred getting the vaccine from government healthcare establishments over private-sector establishments. No significant associations were observed between vaccine acceptance and age or gender. Those who accepted the vaccine were more likely to believe that it should be compulsory (p = 0.00001) and safety measures should be continued even after vaccine administration (p = 0.043). IT-related professionals showed 82.6% vaccine acceptance, healthcare professionals displayed 73.5%, while lawyers showed 53.3% acceptance. There was no association between vaccine acceptance and being a frontline worker, previously having COVID-19, or having a family member who suffered from COVID-19. Despite Delhi and Maharashtra being the highest COVID-19 burden areas, the general population of these two states was more likely to refuse the vaccine than the residents of other states (p = 0.027). Conclusion: This study identified the prevalence of vaccine hesitancy in the Indian population. Consistent dialogue between the government and the public is essential for trust-building. Educational intervention through an evidenced-based approach by government authorities is the need of the hour.

  1. Shereen MA, Khan S, Kazmi A, et al. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. J Adv Res 2020;24:91–98. DOI: 10.1016/j.jare.2020.03.005.
  2. Worldometer. Coronavirus Information. Available from: [Accessed 12 February 2021].
  3. Rahmet G, Hasanoğlu I, Aktaş F. COVID-19: prevention and control measures in community. Turkish J Med Sci 2020;50(SI-1):571–577. DOI: 10.3906/sag-2004-146.
  4. Worldometer. Population Statistics. Available from: [Accessed 12 February 2021].
  5. The World Bank. Available from: [Accessed 12 February 2021].
  6. Indian Council of Medical Research. Worldwide Covid-19 candidate vaccines. Available from: [Accessed on 1 February 2021].
  7. MacDonald NE. SAGE working group on vaccine hesitancy. Vaccine hesitancy: definition, scope and determinants. Vaccine 2015;33(34):4161–4164. DOI: 10.1016/j.vaccine.2015.04.036.
  8. World Health Organisation. Ten threats to global health in 2019. Available from: [Accessed 12 February 2021].
  9. Lazarus JV, Ratzan SC, Palayew A, et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med 2020;2020(2):1124–1129. DOI: 10.1038/s41591-020-1124-9.
  10. Grech V, Gauci C, Agius S. Vaccine hesitancy among Maltese healthcare workers toward influenza and novel COVID-19 vaccination. Early Hum Dev 2020. 105213. DOI: 10.1016/j.earlhumdev.2020. 105213.
  11. Dror AA, Eisenbach N, Taiber S, et al. Vaccine hesitancy: the next challenge in the fight against COVID-19. Eur J Epidemiol 2020;35(8):775–779. DOI: 10.1007/s10654-020-00671-y.
  12. Anderson RM, Vegvari C, Truscott J, et al. Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination. Lancet 2020;396(10263):1614–1616. DOI: 10.1016/S0140-6736(20) 32318-7.
  13. Kumar D, Noor N, Kashyap V. Vaccine hesitancy-issues and possible solutions. J Med Allied Sci 2018;8(2):55–58. DOI: 10.5455/jmas. 290153.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.